<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://biotechmorning.com/news/fda-rejects-replimune-melanoma-drug-twice</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-11T14:12:46.330Z</news:publication_date>
      <news:title>The FDA Just Rejected This Melanoma Drug Twice. Here&apos;s Why It Matters.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/treefrog-ceo-joins-orano-med-alpha-therapy</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-11T14:12:02.188Z</news:publication_date>
      <news:title>Why a Stem Cell CEO Just Ditched His Own Field for Nuclear Medicine</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/medicine-cabinet-strait-of-hormuz-problem</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-11T14:11:15.690Z</news:publication_date>
      <news:title>Your Medicine Cabinet Has a Strait of Hormuz Problem</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/rna-biggest-problem-54m-bet</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-11T14:10:32.882Z</news:publication_date>
      <news:title>RNA&apos;s Biggest Problem Has a $54M Bet Behind It</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/biotech-velvet-rope-q1-2026-ipo-party</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-11T14:09:50.822Z</news:publication_date>
      <news:title>Biotech&apos;s Velvet Rope: Only the Biggest Names Got Into Q1&apos;s IPO Party</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/takeover-tuesday-lilly-biogen-biotech-ma-surge</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-11T14:09:08.033Z</news:publication_date>
      <news:title>Two Pharma Giants Went Shopping on the Same Day. Biotech Went Ballistic.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/oral-glp1-pill-foundayo-obesity-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-11T14:08:26.351Z</news:publication_date>
      <news:title>The Pill That Could Kill the Obesity Needle</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/fda-delay-killed-kezar-life-sciences</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-11T14:07:37.590Z</news:publication_date>
      <news:title>The FDA Canceled a Meeting. A Biotech Company Died.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/biotech-vcs-identity-crisis</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-10T14:14:27.562Z</news:publication_date>
      <news:title>Biotech VCs Are Having an Identity Crisis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/car-t-three-autoimmune-diseases-remission</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-10T14:13:39.823Z</news:publication_date>
      <news:title>One Patient. Three Autoimmune Diseases. All in Remission.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/rfk-jr-peptides-vaccines-contradiction</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-10T14:12:54.759Z</news:publication_date>
      <news:title>America&apos;s Health Secretary Injects Unproven Peptides (But Wants More Vaccine Research)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/avalyn-pharma-ipo-inhaled-lung-therapy</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-10T14:12:12.315Z</news:publication_date>
      <news:title>This Biotech Wants to Turn Lung Medicine Into a 10-Minute Breathing Session</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/why-pharma-still-cant-crack-menopause</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-10T14:11:29.630Z</news:publication_date>
      <news:title>Why Pharma Still Can&apos;t Crack Menopause (and It&apos;s Not for Lack of Trying)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/oricell-110m-car-t-liver-cancer-ipo</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-10T14:10:40.648Z</news:publication_date>
      <news:title>The CAR-T Startup Betting $110M It Can Crack Liver Cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/biotech-next-gold-rush-lpa-inhibitors</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-10T14:09:58.411Z</news:publication_date>
      <news:title>Biotech&apos;s Next Gold Rush Isn&apos;t Where You Think It Is</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://biotechmorning.com/news/gut-bacteria-sugars-als-brain-damage</loc>
    <news:news>
      <news:publication>
        <news:name>Biotech Morning</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-10T14:09:09.572Z</news:publication_date>
      <news:title>Your Gut Bacteria Might Be Giving Your Brain ALS</news:title>
    </news:news>
  </url>
</urlset>